UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1261-1269

2018

Volltextzugriff (PDF)

PNS243 TRENDS IN DECISIONS BY THE SCOTTISH MEDICINES CONSORTIUM OVER THE PAST 10 YEARS - AN ANALYSIS OF KEY FACTORS DRIVING ACCEPTANCE

Value in health, 2019-11, Vol.22, p.S802-S802

Belsey, J.

2019

Volltextzugriff (PDF)

Pre-surgical lung biopsy in management of solitary pulmonary nodules: a cost effectiveness analysis

Journal of medical economics, 2019-12, Vol.22 (12), p.1307-1311

2019

Volltextzugriff (PDF)

SAT0354 Changes in hip fracture and association with osteoporosis-related fracture prevention service initiatives

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.592-592

2013

Volltextzugriff (PDF)

Post-randomization analysis of OS for patients who did not switch to second line targeted therapy in the TIVO-1 study

Annals of oncology, 2016-10, Vol.27, p.vi288-vi288

2016

Volltextzugriff (PDF)

Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

Value in health, 2014-11, Vol.17 (7), p.A679-A679

2014

Volltextzugriff (PDF)

Right ventricular ejection fraction as predictor of outcome in acute heart failure using RV ellipsoid model. A retrospective analysis of a prospective cross-sectional study

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

PHS97 - Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

Value in health, 2018-05, Vol.21, p.S134-S134

2018

Volltextzugriff (PDF)

Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

Value in health, 2018-05, Vol.21, p.S134

2018

Volltextzugriff (PDF)

Global analysis of the burden of osteoporotic fracture: A tool for assessing financial impact within individual countries

Bone (New York, N.Y.), 2009-06, Vol.44, p.S408-S408

2009

Volltextzugriff (PDF)

PCV57 - Estimated Net Cost Impacts Associated With Improved Diagnosis And Treatment of Atrial Fibrillation

Value in health, 2018-09, Vol.21, p.S33-S33

2018

Volltextzugriff (PDF)

Estimated Net Cost Impacts Associated With Improved Diagnosis And Treatment of Atrial Fibrillation

Value in health, 2018-09, Vol.21, p.S33

2018

Volltextzugriff (PDF)

PCV69 - A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions

Value in health, 2017-10, Vol.20 (9), p.A613-A613

2017

Volltextzugriff (PDF)

A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions

Value in health, 2017-10, Vol.20 (9), p.A613

2017

Volltextzugriff (PDF)

PNS292 BUDGET IMPACT OF SOFTWARE SUPPORTING SAFE, EFFECTIVE AND EFFICIENT WORKING OF NHS ACUTE CARE PROVIDERS: ACTUAL BUDGET IMPACT FOR IMPLEMENTATION SITE AND LOST OPPORTUNITY SAVING AND PROJECTED BUDGET IMPACT POTENTIAL FOR OTHER SITES

Value in health, 2019-11, Vol.22, p.S812-S813

2019

Volltextzugriff (PDF)

P3396Urinary drug metabolite testing in heart failure: a novel method for identifying poor adherence

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

The clinical and financial impact of oral triptans - an updated meta-analysis

Journal of medical economics, 2002, Vol.5 (1-4), p.79-89

Belsey, J D

2002

Volltextzugriff (PDF)

PIN86 - Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

Value in health, 2014-11, Vol.17 (7), p.A679-A679

2014

Volltextzugriff (PDF)

Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care

Journal of medical economics, 2002, Vol.5 (1-4), p.39-50

Belsey, Jonathan

2002

Volltextzugriff (PDF)

Oral bowel preparation for colonoscopy: authors' reply

Alimentary pharmacology & therapeutics, 2007-09, Vol.26 (6), p.966-967

2007

Volltextzugriff (PDF)

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

ClinicoEconomics and outcomes research, 2017-01, Vol.9, p.163-172

2017

Volltextzugriff (PDF)

Cancer remains the dominant disease target for biotech through to 2010

Journal of commercial biotechnology, 2006-07, Vol.12 (4), p.294-298

2006

Volltextzugriff (PDF)

An individual patient meta-analysis of clinical trials using dopexamine to increase oxygen delivery in high-risk surgical patients

Critical care (London, England), 2007, Vol.11 (Suppl 2), p.P315-P315

2007

Volltextzugriff (PDF)

Autoimmune and inflammatory disorder biologicals will power biotech market growth through to 2010

Journal of commercial biotechnology, 2006-04, Vol.12 (3), p.237-241

2006

Volltextzugriff (PDF)

Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas

Journal of commercial biotechnology, 2006-10, Vol.13 (1), p.48-51

2006

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(85)

Publikationsform

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(20)
Physical Sciences
(11)
Biological And Medical Sciences
(9)
Chemistry
(9)
Technology
(9)
Infectious Diseases
(6)
Materials Science
(6)
Biotechnology Industry
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Immunology
(5)
Literature
(5)
Materials Science, Multidisciplinary
(5)
Microbiology
(5)
Oncology
(5)
Tropical Medicine
(5)
Virology
(5)
Arthritis
(4)
Birth Control
(4)
Chemistry, Analytical
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains

PNS243 TRENDS IN DECISIONS BY THE SCOTTISH MEDICINES CONSORTIUM OVER THE PAST 10 YEARS - AN ANALYSIS OF KEY FACTORS DRIVING ACCEPTANCE

Pre-surgical lung biopsy in management of solitary pulmonary nodules: a cost effectiveness analysis

SAT0354 Changes in hip fracture and association with osteoporosis-related fracture prevention service initiatives

Post-randomization analysis of OS for patients who did not switch to second line targeted therapy in the TIVO-1 study

Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

Right ventricular ejection fraction as predictor of outcome in acute heart failure using RV ellipsoid model. A retrospective analysis of a prospective cross-sectional study

PHS97 - Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

Global analysis of the burden of osteoporotic fracture: A tool for assessing financial impact within individual countries

PCV57 - Estimated Net Cost Impacts Associated With Improved Diagnosis And Treatment of Atrial Fibrillation

Estimated Net Cost Impacts Associated With Improved Diagnosis And Treatment of Atrial Fibrillation

PCV69 - A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions

A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions

PNS292 BUDGET IMPACT OF SOFTWARE SUPPORTING SAFE, EFFECTIVE AND EFFICIENT WORKING OF NHS ACUTE CARE PROVIDERS: ACTUAL BUDGET IMPACT FOR IMPLEMENTATION SITE AND LOST OPPORTUNITY SAVING AND PROJECTED BUDGET IMPACT POTENTIAL FOR OTHER SITES

P3396Urinary drug metabolite testing in heart failure: a novel method for identifying poor adherence

The clinical and financial impact of oral triptans - an updated meta-analysis

PIN86 - Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care

Oral bowel preparation for colonoscopy: authors' reply

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

Cancer remains the dominant disease target for biotech through to 2010

An individual patient meta-analysis of clinical trials using dopexamine to increase oxygen delivery in high-risk surgical patients

Autoimmune and inflammatory disorder biologicals will power biotech market growth through to 2010

Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas

Aktive Filter

Suchergebnisse filtern